Michael W. Kalb
Net Worth
Last updated:
What is Michael W. Kalb net worth?
The estimated net worth of Mr. Michael W. Kalb is at least $14,772,985 as of 1 Aug 2022. He owns shares worth $3,300,661 as insider, has earned $6,875,704 from insider trading and has received compensation worth at least $4,596,620 in null.
What is the salary of Michael W. Kalb?
Mr. Michael W. Kalb salary is $656,660 per year as Chief Financial Officer, Senior Vice President & Assistant Sec. in null.
How old is Michael W. Kalb?
Mr. Michael W. Kalb is 54 years old, born in 1971.
What stocks does Michael W. Kalb currently own?
As insider, Mr. Michael W. Kalb owns shares in one company:
What does do?
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. The company sells its products principally to wholesalers and specialty pharmacy providers. It has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa, the omega-3 acid, and eicosapentaenoic acid. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin, Ireland.
Michael W. Kalb insider trading
Mr. Michael W. Kalb has made 9 insider trades between 2018-2022, according to the Form 4 filled with the SEC.
The largest trade he's ever made was exercising 200,000 units of AMRN stock on 9 Jan 2019. As of 1 Aug 2022 he still owns at least 205,010 units of AMRN stock.
key executives
executives and other stock owners filed with the SEC:
- Dr. Steven B. Ketchum (60) Pres of R&D, Senior Vice President and Chief Scientific Officer
- Mr. Aaron D. Berg (62) Executive Vice President & Pres of U.S.
- Mr. Michael W. Kalb (54) Chief Financial Officer, Senior Vice President & Assistant Sec.